Your browser doesn't support javascript.
loading
Should we move to a genomic classification of neutrophilic myeloid neoplasms?
Carreño-Tarragona, Gonzalo; Álvarez-Larrán, Alberto; Hernández-Boluda, Juan Carlos; Ayala, Rosa; Cross, Nicholas C P.
Affiliation
  • Carreño-Tarragona G; Department of Hematology, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain.
  • Álvarez-Larrán A; Department of Hematology, Hospital Clínic, Barcelona, Spain.
  • Hernández-Boluda JC; Department of Hematology, Hospital Clínico, Valencia, Spain.
  • Ayala R; Department of Hematology, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain.
  • Cross NCP; Wessex Genomic Laboratory Service, Salisbury, United Kingdom.
Blood Adv ; 7(21): 6705-6706, 2023 11 14.
Article in En | MEDLINE | ID: mdl-37672387
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloproliferative Disorders / Neoplasms Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloproliferative Disorders / Neoplasms Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Affiliation country: Country of publication: